Next-generation sequencing and immuno-histochemistry profiling identify numerous biomarkers for personalized therapy of endometrioid endometrial carcinoma

Said El Shamieh 1, Fatima Saleh 1, Mirna A Fawaz 1, Gérard Siest 1, Fadi S Farhat 1, Sophie Visvikis-Siest 1

PMID: 28763293

DOI: 10.1515/cclm-2017-0208

No abstract available

Keywords: endometrial carcinoma; immunohistochemistry; next-generation sequencing; personalized therapy.